Perion Network: Risks All Priced In, Time To Buy The Cash Play
https://seekingalpha.com/article/4693048-perion-network-risks-all-priced-in-time-to-buy-cash-play?source=feed_tag_israel
May 14, 2024 - Perion Network's current valuation barely accounts for its robust cash position, representing 75% of its market cap. Read more about PERI stock here.
0
Movano Evie Ring Review: Running Out of Time
https://www.wired.com/review/movano-evie-ring/
May 14, 2024 - For tracking women’s health, the Evie ring is still underbaked. Competitors like Samsung, Oura, and Apple may already have you covered.
0
Dodgers’ slumping Chris Taylor has seen his playing time disappear
https://www.ocregister.com/2024/05/13/dodgers-slumping-chris-taylor-has-seen-his-playing-time-disappear/
May 13, 2024 - Batting just .071 this season, Taylor has just seven at-bats this month, with Andy Pages, Kiké Hernandez and Miguel Rojas getting the time at second base or in center field that might have gone to Taylor in other years.
0
HEQT: Good Timing For A Hedged Play That's Different
https://seekingalpha.com/article/4692855-heqt-good-timing-for-a-hedged-play-thats-different?source=feed_tag_etf_portfolio_strategy
May 13, 2024 -
0
Earnings Estimates Moving Higher for Kirby (KEX): Time to Buy?
https://www.zacks.com/stock/news/2273058/earnings-estimates-moving-higher-for-kirby-kex-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2273058
May 13, 2024 - Kirby (KEX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
0
New York Times Co. (NYT) is a Great Momentum Stock: Should You Buy?
https://www.zacks.com/stock/news/2273022/new-york-times-co-nyt-is-a-great-momentum-stock-should-you-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2273022
May 13, 2024 - Does New York Times Co. (NYT) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
https://www.zacks.com/stock/news/2272961/moderna-mrna-falls-as-fda-extends-review-time-for-rsv-vaccine?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2272961
May 13, 2024 - Moderna's (MRNA) RSV vaccine, mRNA-1345's review timeline gets delayed. A decision is now expected by the end of May.
0
Time to Buy These 3 Auto Stocks on Raised Forecasts?
https://www.zacks.com/stock/news/2272905/time-to-buy-these-3-auto-stocks-on-raised-forecasts?cid=CS-ZC-FT-analyst_blog|investment_ideas-2272905
May 13, 2024 - Auto players like GM, BWA and OSK lift 2024 guidance. Are these upward forecasts enough to consider investing in these auto stocks?
0
Sterling Infrastructure, Inc. (STRL) Soars to 52-Week High, Time to Cash Out?
https://www.zacks.com/stock/news/2272693/sterling-infrastructure-inc-strl-soars-to-52-week-high-time-to-cash-out?cid=CS-ZC-FT-52_week_high-2272693
May 13, 2024 - Sterling Infrastructure (STRL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
0
SilverCrest Metals Inc. (SILV) Soars to 52-Week High, Time to Cash Out?
https://www.zacks.com/stock/news/2272703/silvercrest-metals-inc-silv-soars-to-52-week-high-time-to-cash-out?cid=CS-ZC-FT-52_week_high-2272703
May 13, 2024 - SilverCrest Metals (SILV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
0